17/09/2020 (Agence Europe) – Nearly half of the future doses of the Covid-19 vaccine have already been purchased by a limited number of rich countries who account for barely a tenth of the population, according to a report released by Oxfam on Wednesday 16 September. According to analysis conducted by the non-governmental organisation on candidate vaccines clinically tested in Phase 3, the United States, the United Kingdom, the European Union, Australia, Hong Kong, Switzerland and Israel...